Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Plummer

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Organic Letters|February 25, 2012
Sequential allylic C-H amination/vinylic C-H arylation: a strategy for unnatural amino acid synthesis from α-olefinsChao Jiang, Dustin J Covell, Antonia F Stepan, et al.
Tetrahedron|March 8, 2011
Diversification of a β-Lactam Pharmacophore via Allylic C-H Amination: Accelerating Effect of Lewis Acid Co-CatalystXiangbing Ben Qi, Grant T Rice, Manjinder S Lall, et al.
Journal of the American Chemical Society|April 15, 2011
Divergent C-H functionalizations directed by sulfonamide pharmacophores: late-stage diversification as a tool for drug discoveryHui-Xiong Dai, Antonia F Stepan, Mark S Plummer, et al.
Chemistry & Biology|April 25, 2015
Small molecule fluoride toxicity agonistsJames W Nelson, Mark S Plummer, Kenneth F Blount, et al.
Journal of Medicinal Chemistry|January 17, 2012
Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generationJun Yong Choi, Mark S Plummer, Jeremy Starr, et al.
Journal of Medicinal Chemistry|May 29, 2013
Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a toolMarina Shalaeva, Giulia Caron, Yuriy A Abramov, et al.
Organic Letters|September 14, 2011
One-pot (1-ethoxycarbonylcyclopropyl)triphenylphosphonium tetrafluoroborate ring-opening and Wittig reactionSeung Won Chung, Mark S Plummer, Laura A McAllister, et al.
ACS Infectious Diseases|April 15, 2024
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of <i>Mycobacterium tuberculosis</i>Mary Nantongo, David C Nguyen, Christopher R Bethel, et al.
Bioorganic & Medicinal Chemistry|December 12, 2001
Structure-based design of nonpeptide inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1)Aurash B Shahripour, Mark S Plummer, Elizabeth A Lunney, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Organic Letters|February 25, 2012
Sequential allylic C-H amination/vinylic C-H arylation: a strategy for unnatural amino acid synthesis from α-olefinsChao Jiang, Dustin J Covell, Antonia F Stepan, et al.
Tetrahedron|March 8, 2011
Diversification of a β-Lactam Pharmacophore via Allylic C-H Amination: Accelerating Effect of Lewis Acid Co-CatalystXiangbing Ben Qi, Grant T Rice, Manjinder S Lall, et al.
Journal of the American Chemical Society|April 15, 2011
Divergent C-H functionalizations directed by sulfonamide pharmacophores: late-stage diversification as a tool for drug discoveryHui-Xiong Dai, Antonia F Stepan, Mark S Plummer, et al.
Chemistry & Biology|April 25, 2015
Small molecule fluoride toxicity agonistsJames W Nelson, Mark S Plummer, Kenneth F Blount, et al.
Journal of Medicinal Chemistry|January 17, 2012
Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generationJun Yong Choi, Mark S Plummer, Jeremy Starr, et al.
Journal of Medicinal Chemistry|May 29, 2013
Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a toolMarina Shalaeva, Giulia Caron, Yuriy A Abramov, et al.
Organic Letters|September 14, 2011
One-pot (1-ethoxycarbonylcyclopropyl)triphenylphosphonium tetrafluoroborate ring-opening and Wittig reactionSeung Won Chung, Mark S Plummer, Laura A McAllister, et al.
ACS Infectious Diseases|April 15, 2024
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of <i>Mycobacterium tuberculosis</i>Mary Nantongo, David C Nguyen, Christopher R Bethel, et al.
Bioorganic & Medicinal Chemistry|December 12, 2001
Structure-based design of nonpeptide inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1)Aurash B Shahripour, Mark S Plummer, Elizabeth A Lunney, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Pageof 2